Regular paper
Disparate effects of neuropeptide Y and clonidine on the excretion of sodium and water in the rat

https://doi.org/10.1016/0014-2999(88)90848-5Get rights and content

Abstract

Previous studies have demonstrated a similarity between the ability of neuropeptide Y (NPY) and clonidine to inhibit renin release and inhibit cAMP production. We therefore compared the effects of clonidine and NPY on the excretion of sodium and water in anesthetized rats which were unilaterally nephrectomized (right kidney) 10 days prior to the experiment. On the experimental day, rats were anesthetized (nembutal) and the left kidney exposed for the intrarenal infusion of the study drugs. The lowest dose of NPY (0.3 μg/kg per min) investigated failed to alter renal function. Clonidine (0.3 μg/kg per min) and NPY (1 μg/kg per min) produced a similar increase in urine volume. Only NPY increased sodium excretion and osmolar clearance. Free water clearance was only increased by clonidine. Blood pressure and creatinine clearance were similar in all groups investigated. These effects were attenuated by pretreatment with pertussis toxin (5 days). The ability of pertussis toxin to block these effects suggests that the renal effects of NPY and clonidine are coupled to a G protein, conceivably the inhibitory Gi protein of the adenylate cyclase system. The disparate effects on sodium excretion and on free water and osmolar clearance indicate that the effects of these compounds may be mediated through the inhibition of different pools of hormonally stimulated cAMP.

References (20)

  • R.K. Krothapolli et al.

    Modulation of the hydro-osmotic effect of vasopressin on the rabbit cortical collecting tubule by adrenergic agents

    J. Clin. Invest.

    (1983)
  • J. Pedraza-Chaverri et al.

    Effect of pertussis toxin on the adrenergic regulation of plasma renin activity

    Life Sci.

    (1984)
  • C. Wahlestedt et al.

    Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: Mode of action

    J. Pharmacol. Exp. Ther.

    (1985)
  • J.M. Allen et al.

    Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity

    Clin. Sci.

    (1985)
  • J. Ballesta et al.

    The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY

    Histochemistry

    (1984)
  • R.M. Edwards et al.

    Inhibition of vasopressin-stimulated cyclic AMP accumulation by alpha2-adrenoceptor agonists in isolated papillary collecting ducts

    J. Pharmacol. Exp. Ther.

    (1988)
  • B.B. Fredholm et al.

    Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels

    Acta Physiol. Scand.

    (1985)
  • E. Hackenthal et al.

    Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism

    Am. J. Physiol.

    (1987)
    E. Hackenthal et al.

    Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism

    Renal Fluid Electrolyte Physiol.

    (1987)
  • T. Katada et al.

    ADP-ribosylation of the specific membrane protein of CG-cells by islet activating protein associated with modification of adenylate cyclase

    J. Biol. Chem.

    (1982)
  • J.M. Lundberg et al.

    Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade

    Acta Physiol. Scand.

    (1982)
There are more references available in the full text version of this article.

Cited by (17)

View all citing articles on Scopus
View full text